Equimed Alliance was founded to help global biopharma companies navigate the complexity of U.S. regulatory pathways and translate innovation into commercially viable products.
Founded by a team of seasoned biopharma executives with 70+ years of collective experience across formulation development, regulatory strategy, IP planning and commercialization.
Global innovators often face fragmented decision-making across regulatory, development, IP, and commercialization functions. Equimed Alliance was created to bring these elements together—ensuring that early-stage decisions are aligned with downstream success.
Regulatory, IP, CMC, and commercial decisions aligned from the outset.
Practical, implementation-driven support—not just advisory.
Bridging international innovation with U.S. regulatory and market realities.
Understand your goals, assets and challenges
Analyse key gap areas using our AI platform and develop regulatory, CMC, IP and Commercial strategy
Drive execution with the right partners and cross-functional coordination
Achieve submission readiness and regulatory milestones
Support launch and lifecycle value maximization
Partners
Supporting development and regulatory strategy for biosimilars and complex biologic products.
Advising on regulatory pathways for complex formulations and value-added generic products.
Helping global innovators navigate FDA pathways and prepare for successful U.S. market entry.
Collaborating with manufacturers and CMOs to ensure compliance, quality, and regulatory alignment.
Partnering with emerging companies to build a strong regulatory and commercial foundation.